Stomatococcus mucilaginosus septicemia in leukemic patients

Clinical Microbiology and Infection

Volumn 2, Issue 3, 1996, Pages 179-185

  Granlund, Margareta ^a,b   Linderholm, Mats ^a   Norgren, Mari ^a   Olofsson, Carin ^a   Wahlin, Anders ^a   Holm, Stig E ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Antibiotic prophylaxis; Ciprofloxacin resistance; Neutropenia; Restriction fragment length polymorphism; Septicemia; Stomatococcus mucilaginosus

Indexed keywords

EID: 0000591867     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1198-743X(14)65140-5     Document Type: Article

References (26)

1. Bodey GP, Buckely M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-40.
2. Pizzo PA, Ladisch SL, Gill F, Levine AS. Increasing incidence of gram-positive sepsis in cancer patients. Med Pediatr Oncol 1078; 5: 241-4.
3. Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DAG. Septicemia caused by viridans streptococci in neutropenic patients with leukemia. Lancet 1983; ii: 1452-4.
4. Brown AE. Neutropenia, fever, and infection. Am J Med 1984; 76: 421-8.
5. . Sotiropoulos S, Jackson MA, Woods GM, Hicks RA, Cullen J, Freeman AI. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J 1989; 8: 755-8.
6. Kern W, Kurrle E, Vanek E. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. Klin Wochensch 1987; 65: 773-80.
7. Kern W, Kurrle E, Vanek E. Ofloxacin for prevention of bacterial infections in granulocytopenic patients. Infection 1987; 15: 427-32.
8. De Pauw BE, Donnelly JP, DeWitte T, Nova-Kova IRO, Schattenberg A. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogenic bone marrow transplant recipients. Bone Marrow Transplant 1990; 5: 179-82.
9. Rubin SJ, Lyons RW, Murcia AJ. Endocarditis associated with cardiac catheterizarion due to a gram-positive coccus designated Micrococcus mucilaginosus. J Clin Microbiol 1978; 7: 546-9.
10. Bergan T, Kocur M. Stomatococcus mucilaginosus gen. nov., sp. nov., ep. rev., a member of the family Micrococcaceae Int J Syst Bacteriol 1982; 32: 374-7.
11. Ascher DP, Zbick C, White C, Fischer G. Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis 1991; 13: 1048-52.
12. McWhinney PH, Kibbler CC, Gillespie SH, et al. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis 1992; 14: 641-6.
13. Oppenheim BA, Weightman NC, Prendeville J. Fatal Stomatococcus mucilaginosus septicaemia in a neutropenic patient. Eur J Clin Microbiol Infect Dis 1989; 8: 1004-5.
14. Mustafa MM, Carlson L, Krisher K. Stomatococcus mucilaginosus fatal sepsis in a child with leukemia. Pediatr Infect Dis J 1993; 12: 784-5.
15. Henwick S, Koehler M, Patrick C. Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children. Clin Infect Dis 1993; 17: 667-71.
16. Beighton JM, Hardie JM, Whiley RA. A scheme for the identification of viridans streptococci. J Med Microbiol 1991; 53: 367-72.
17. Fasola E, Livdahl C, Ferrieri P. Molecular analysis of multiple isolates of the major serotypes of group B streptococci. J Clin Microbiol 1993; 31: 2616-20.
18. Smith CL, Cantor CR. Purification, specific fragmentation, and separation of large DNA molecules. Methods Enzymol 1987; 155: 449-67.
19. Krumholz HM, Cummings S, York M. Blood culture phlebotomy: switching needles does not prevent contamination. Ann Intern Med 1990; 113: 290-2.
20. Roberts FJ. The value of the second blood culture. J Infect Dis 1993; 168: 795-6.
21. Mitchell PS, Huston BJ, Jones RN, Holcomb L, Koontz FP. Stomatococcus mucilaginosus bacteremias. Diagn Microbiol Infect Dis 1990; 13: 521-5.
22. Wolfson JS, Hooper DC. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 1985; 28: 581-6.
23. Archer GL, Climo MW. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 1994; 38: 2231-7.
24. Sreedharan S, Peterson LR, Fisher LM. Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 1991; 35: 2151-4.
25. Piddock LJV. New quinolones and gram-positive bacteria. Antimicrob Agents Chemother 1994; 38: 163-9.
26. Cruciani M, Bassetti D. The fluoroquinolones as treatment for infections caused by gram-positive bacteria. J Antimicrob Chemother 1994; 33: 403-17.